Research Grade Anti-Human CEA & CD3 Bispecific Antibody (MEDI-565)

Anti-Human CEA & CD3 Bispecific Antibody (MEDI-565) ( HY546126 ) is a research-grade recombinant antibody targeting CD66 . Produced in mammalian cells with native-like glycosylation. Highlights Research Grade — For PK/PD studies, assay development, and ADA research. Native Glycosylation — Mammalian expression ensures native-like patterns.

Спецификация

Species reactivity	Human
Applications	ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Form	Liquid
Storage	-20℃
Product category‌	Biosimilar
Target	Carcinoembryonic antigen-related cell adhesion molecule 5, Carcinoembryonic antigen, CEA, Meconium antigen 100, CD66e, CEACAM5, CEA, T-cell surface glycoprotein CD3 epsilon chain, T-cell surface antigen T3/Leu-4 epsilon chain, CD3e, CD3E, T3E
Accession	P06731 & P07766
Host species	Human

Информация для заказа

Область использования: Антитела Puda	Производство:	Puda Scientific
	Метод:	Иммуногистохимия
	Объем:	1mg
	Кат. номер:	PD-A26-590-100
Цена (с НДС 22%):	по запросу	В корзину
Наименование: Research Grade Anti-Human CEA & CD3 Bispecific Antibody (MEDI-565). Примечание: